198 related articles for article (PubMed ID: 17277347)
1. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Kamrath C; Maser-Gluth C; Haag C; Schulze E
Horm Res Paediatr; 2011; 76(2):93-8. PubMed ID: 21625068
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.
Mulatero P; Veglio F; Pilon C; Rabbia F; Zocchi C; Limone P; Boscaro M; Sonino N; Fallo F
J Clin Endocrinol Metab; 1998 Jul; 83(7):2573-5. PubMed ID: 9661646
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
6. Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
Ding W; Liu L; Hu R; Xu M; Chen J
Chin Med J (Engl); 2002 Jul; 115(7):979-82. PubMed ID: 12150724
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Mulatero P; di Cella SM; Williams TA; Milan A; Mengozzi G; Chiandussi L; Gomez-Sanchez CE; Veglio F
J Clin Endocrinol Metab; 2002 Jul; 87(7):3187-91. PubMed ID: 12107222
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
Litchfield WR; New MI; Coolidge C; Lifton RP; Dluhy RG
J Clin Endocrinol Metab; 1997 Nov; 82(11):3570-3. PubMed ID: 9360508
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype.
Rich GM; Ulick S; Cook S; Wang JZ; Lifton RP; Dluhy RG
Ann Intern Med; 1992 May; 116(10):813-20. PubMed ID: 1567095
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-remediable aldosteronism.
McMahon GT; Dluhy RG
Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-remediable aldosteronism.
Halperin F; Dluhy RG
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
[TBL] [Abstract][Full Text] [Related]
13. Rapid diagnosis and identification of cross-over sites in patients with glucocorticoid remediable aldosteronism.
MacConnachie AA; Kelly KF; McNamara A; Loughlin S; Gates LJ; Inglis GC; Jamieson A; Connell JM; Haites NE
J Clin Endocrinol Metab; 1998 Dec; 83(12):4328-31. PubMed ID: 9851772
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid remediable aldosteronism: a case report.
Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
[TBL] [Abstract][Full Text] [Related]
15. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
16. A Chinese pedigree with glucocorticoid remediable aldosteronism.
Liu X; Jin L; Zhang H; Ma W; Song L; Zhou X; Cai J
Hypertens Res; 2021 Nov; 44(11):1428-1433. PubMed ID: 34462604
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis.
Dluhy RG; Lifton RP
Steroids; 1995 Jan; 60(1):48-51. PubMed ID: 7792815
[TBL] [Abstract][Full Text] [Related]
18. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
20. [Remediable glucocorticoid hyperaldosteronism: molecular diagnosis].
Lurbe E; Chaves FJ; Torró I; Armengod ME; Alvarez V; Redon J
Med Clin (Barc); 1999 Nov; 113(15):579-82. PubMed ID: 10605685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
